Nedosiran in Pediatric Patients From Birth to 11 Years of Age With PH and Relatively Intact Renal Function

Clinical trial NCT05001269 · COMPLETED

Trial details

NCT number: NCT05001269
Sponsor: Dicerna Pharmaceuticals, Inc., a Novo Nordisk company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Primary Hyperoxaluria Primary Hyperoxaluria Type 1 Primary Hyperoxaluria Type 2 Primary Hyperoxaluria Type 3

Start date: 2022-02-22
Primary completion: 2025-02-05
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.